MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MicroVision, Inc. furnished a new investor presentation under Regulation FD. The presentation, dated April 2026, is available on the company’s investor relations website and is attached as Exhibit 99.1. MicroVision expects to use this deck, in whole or in part, in presentations to investors, analysts and others throughout 2026.
The company states that the information in the presentation is summary in nature and should be read together with its SEC filings and other public announcements. The material is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and will not be automatically incorporated into Securities Act registration statements.
MICROVISION, INC. CEO Glen W. DeVos reported routine equity compensation activity involving restricted stock units and related tax withholding. On March 31, 2026, 325,000 vested restricted stock units converted into an equal number of common shares. On April 2, 2026, the company completed a tax-related nondiscretionary sell-to-cover transaction, withholding 153,230 common shares at a weighted average price of $0.6403 per share in multiple trades between $0.6402 and $0.6408. Following these transactions, DeVos directly holds 359,670 shares of MicroVision common stock. The filing reflects compensation vesting and tax settlement rather than open-market buying or selling by the CEO.
The Vanguard Group filed Amendment No. 3 to Schedule 13G/A reporting 0 shares of MicroVision Inc. common stock as beneficially owned. The filing explains an internal realignment and disaggregation under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately. The amendment is signed by Ashley Grim on 03/27/2026.
MicroVision, Inc. Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of the company’s common stock on March 15, 2026. The shares were purchased directly from MicroVision under a Subscription Agreement at $0.5322 per share, the closing price on March 13, 2026, in a transaction intended to be exempt under Rule 16b-3. Following this acquisition, Biddiscombe directly holds 385,249 MicroVision shares.
MicroVision director Jeffrey A. Herbst acquired 28,185 shares of common stock directly from the company at $0.5322 per share under a Subscription Agreement executed on March 15, 2026. The purchase price matched the closing share price on March 13, 2026 and is intended to qualify as an exempt transaction under Rule 16b-3. Following this acquisition, Herbst directly holds 258,912 shares of MicroVision common stock.
MicroVision director Robert Paul Carlile acquired additional shares of the company’s common stock. On March 15, he obtained 187,900 shares directly from MicroVision under a Subscription Agreement at $0.5322 per share, matching the March 13 closing price. This increased his direct holdings to 538,699 shares. The purchase is intended to qualify as an exempt transaction under Rule 16b-3, meaning it is structured within specific insider trading exemption rules rather than as an open-market trade.
MicroVision director Laura J. Peterson acquired 37,580 shares of common stock from the company under a subscription agreement. The shares were purchased directly from MicroVision at a price of $0.5322 per share, matching the closing price on March 13, 2026.
After this exempt Rule 16b-3 transaction, Peterson directly holds 91,596 MicroVision shares. This reflects a compensation-related or insider-aligned acquisition rather than an open-market trade.
MicroVision, Inc. CEO Glen W. DeVos reported an acquisition of company stock. On March 15, 2026, he acquired 187,900 shares of MicroVision common stock directly from the company at $0.5322 per share under a Subscription Agreement, matching the March 13, 2026 closing price.
Following this transaction, DeVos directly holds 187,900 shares. A footnote states the purchase is intended to be an exempt transaction pursuant to Rule 16b-3.
MicroVision director Jada Smith acquired 28,185 shares of common stock directly from the company in a subscription transaction. The shares were purchased at $0.5322 per share, matching the closing price of MicroVision stock on March 13, 2026.
After this grant/award acquisition, Smith directly owns 154,543 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions with the issuer.
MicroVision, Inc. general counsel Drew G. Markham acquired 9,395 shares of common stock directly from the company on March 15, 2026. The purchase price was $0.5322 per share, matching the closing price on March 13, 2026 as set by a subscription agreement.
Following this transaction, Markham directly holds 388,329 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which generally covers certain insider transactions approved under specific governance procedures.